From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 12,359,458 shares, representing 13.58% for $2,946.8 million under the buyback announced on December 9, 2021.
Laboratory Corporation of America Holdings
Equities
LH
US50540R4092
Healthcare Facilities & Services
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
205.3 USD | -0.75% | -2.77% | -9.65% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.65% | 17.43B | |
+18.37% | 85.14B | |
-27.46% | 72.06B | |
+2.75% | 27.07B | |
-1.96% | 16.98B | |
+3.68% | 16.02B | |
+8.48% | 13.87B | |
+72.56% | 13.06B | |
+73.15% | 12.79B | |
+33.13% | 12.36B |
- Stock Market
- Equities
- LH Stock
- News Laboratory Corporation of America Holdings
- Tranche Update on Laboratory Corporation of America Holdings (NYSE: LH)'s Equity Buyback Plan announced on December 9, 2021.